A systematic review of community opioid overdose prevention and naloxone distribution programs

The ASAM Principles of Addiction Medicine: Fifth Edition

Volumn , Issue , 2014, Pages

  Clark, Angela K ^a   Wilder, Christine M ^b   Winstanley, Erin L ^b,c  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974588718     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (27)

1. National Center for Injury Prevention and Control. Data and statistics web-based injury statistics query and reporting system 2005. 2013. Accessed Sept 13 2013, at http://www.cdc.gov/injury/wisqars/LeadingCauses.html
2. Centers for Disease Control and Prevention. Vital signs: overdoses of prescription opioid pain relievers-United States, 1999-2008. Morb Mortal Wkly Rep 2011;60:1487-1492.
3. Jones JD, Roux P, Stancliff S, et al. Brief overdose education can significantly increase accurate recognition of opioid overdose among heroin users. Int J Drug Policy 2013;25(1):166-170.
4. Buajordet I, Naess A, Jacobsen D, et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004;11:19-23.
5. Clarke S, Dargan P, Jones A. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J 2005;22:612-616.
6. Dahan A, Aarts L, Smith TW. Incidence, reversal, and pre vention of opioid-induced respiratory depression. Anesthesiology 2010;112:226-238.
7. Boyer EW. Management of opioid analgesic overdose. N Eng J Med 2012;367:146-155.
8. Wheeler E, Davidson PJ, Jones TS, et al. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. Morb Mortal Wkl Rep 2012;61:101-105.
9. Sporer KA, Kral AH. Prescription naloxone: a novel approach to heroin overdose prevention. Ann Rmerg Med 2007;49: 172-177.
10. Davis C, Webb D, Burris S. Changing law from barrier to facilitator of opioid overdose prevention. J Law Med Ethics 2013;41(Suppl 1):33-36.
11. Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health 2010;87:931-941.
12. Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med (In press).
13. Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse 2008;43:858-870.
14. Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Educ Prev Policy 2012;19:320-328.
15. Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health 2009;99:788-791.
16. Walley AY, Doe-Simkins M, Quinn E, et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat 2013;44:241-247.
17. Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ (Clinical research ed) 2013;346:f174.
18. Bennett AS, Bell A, Tomedi L, et al. Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health 2011;88:1020-1030.
19. Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis 2006;25:89-96.
20. Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy 2010;21:186-193.
21. Galea S, Worthington N, Markham Piper T, et al. Provision of naloxone to injection drug users as an overdose prevention strategy: early evidence from a pilot study in New York City. Addict Behav 2006;31:907-912.
22. Lankenau SE, Wagner KD, Silva K, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health 2013;38:133-141.
23. Tobin KE, Sherman SG, Beilenson P, et al. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy 2009;20:131-136.
24. Lopez Gaston R, Best D, Manning V, et al. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduct J 2009;6:26.
25. Sherman SG, Gann DS, Scott G, et al. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J 2008;5:2.
26. Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction 2008;103:1648-1657.
27. McAuley A, Lindsey G, Woods M, et al. Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Policy 2010;17:388-399.